Britannia Life Sciences Inc. (CSE:BLAB)
Canada
· Delayed Price · Currency is CAD 0.0900
0.00 (0.00%)
Apr 28, 2026, 1:02 PM EST
Britannia Life Sciences Revenue
Britannia Life Sciences had revenue of 65.36K CAD in the quarter ending December 31, 2025, a decrease of -61.16%. This brings the company's revenue in the last twelve months to 157.68K, down -103.31% year-over-year. In the fiscal year ending March 31, 2025, Britannia Life Sciences had annual revenue of 369.28K, down -28.55%.
Revenue (ttm)
157.68K
Revenue Growth
-103.31%
P/S Ratio
92.61
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.60M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rapid Dose Therapeutics | 2.78M |
| Pharmala Biotech Holdings | 889.57K |
| Innovotech | 4.53M |
| Glow Lifetech | 2.05M |
| COSCIENS Biopharma | 10.28M |